U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06884215) titled 'Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers' on March 13.
Brief Summary: The objective of this study is to investigate the irritation and sensitization potential of multiple topically applied test articles (containing different concentrations of Mitopure), in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modified Draize method
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Irritation/Irritant
Sensitisation
Intervention:
OTHER: Mitopure Topical Formula 3
Top...